February 28th 2025
While pain is a common deterrent for patients considering an IUD, there are no standardized guidelines for pain relief during insertion or removal.
Identifying Health Care Inequities in Screening, Diagnosis, and Trial Access for Breast Cancer Care: Taking Action With Evidence-Based Solutions
View More
16th Annual International Symposium on Ovarian Cancer and Other Gynecologic Malignancies™
May 3, 2025
View More
Addressing Healthcare Inequities: Tailoring Cancer Screening Plans to Address Inequities in Care
View More
Clinical Consultations™: Guiding Patients with Genital Psoriasis Toward Relief Through a Multidisciplinary Approach
View More
Burst CME™: The Patient Journey – Unmet Needs From Diagnosis Through Management of Migraine
View More
Burst CME™: Setting the Stage – Individualizing Migraine Care for Diverse Populations Across Care Settings
View More
Burst CME™: Optimizing the Use of CGRP Targeted Agents for the Treatment of Migraine
View More
Burst CME™: Optimizing Migraine Management – Addressing Unmet Needs, Individualizing Care for Diverse Populations, and Utilizing CGRP Targeted Agents
View More
‘REEL’ Time Patient Counseling™: Fostering Effective Conversations in Practice to Create a Visible Impact for Patients Living with Genital Psoriasis
View More
Navigating Low-Grade Serous Ovarian Cancer – Enhancing Diagnosis, Sequencing Therapy, and Contextualizing Novel Advances
View More
Burst CME™: Implementing Appropriate Recognition and Diagnosis of Low-Grade Serous Ovarian Cancer
View More
Burst CME™: Stratifying Therapy Sequencing for LGSOC and Evaluating the Unmet Needs of the Standard of Care
View More
Burst CME™: Understanding Novel Advances in LGSOC—A Focus on New Mechanisms of Action and Clinical Trials
View More
Cases and Conversations™: Navigating the Complexities of Managing Myasthenia Gravis in Pediatric and Pregnant Patient Populations
View More
Expert Illustrations and Commentaries™: Visualizing Glucocorticoid Receptor Modulation in Platinum-Resistant Ovarian Cancer—Looking at Novel Pathways With an Eye Toward the Future of Treatment
View More
Data still hazy for immediate postpartum hormonal contraception and postpartum depression
May 6th 2022A recent study presented at the 2022 American College of Obstetricians & Gynecologists' Annual Clinical & Scientific Meeting found that there was neither a decreased nor increased risk for postpartum depression in patients who received hormonal contraception due to insufficient evidence.
Read More
Combined oral contraceptives for patients with rheumatoid arthritis
February 8th 2022While the use of combined oral contraceptives (COCs) among patients with rheumatoid and autoimmune disorders have focused on safety, a narrative review in the Journal of Obstetrics and Gynaecology Research highlighted the efficacy and benefits of these contraceptives in females with rheumatoid arthritis (RA).
Read More
Efficacy of combined oral contraceptives for treating depression in premenstrual women
February 7th 2022Combined oral contraceptives were found to be moderately more efficacious than placebo for treating overall premenstrual symptomatology in women with premenstrual syndrome (PMS) or premenstrual dysphoric disorder (PMDD).
Read More
Balancing the rewards and risks of hormonal acne treatments
January 31st 2022Julie Harper, MD, of the Dermatology and Skin Care Center of Birmingham, Alabama explained the use, side effects, and risks of spironolactone and oral contraceptives in a presentation at the current Maui Derm for Dermatologists meeting in Maui, Hawaii.
Read More
Impact of contraceptive coverage policies
January 13th 2022The findings support previous research demonstrating that increased access to emergency contraception does not compromise use of other more effective methods or lead to an increase in reported levels of unprotected sexual intercourse, according to Hawkins.
Read More
Counseling on adverse events of intrauterine contraception
December 2nd 2021Professionals who provide contraception counseling need sufficient training and resources to offer comprehensive information about adverse reactions of intrauterine contraception, according to 2 web-based discussion boards about sexual and reproductive health.
Read More
Increasing access to contraception in the United States
November 11th 2021One year after the close of the Increasing Access to Contraception (IAC) Learning Community, participants had sustained their efforts in support of at least 1 goal: to improve women’s access to the full range of contraceptive options.
Read More
Certain incentives may help those with OUD prevent unintended pregnancy
September 10th 2021Among women with opioid use disorder (OUD) at high risk for unintended pregnancy, on-site contraceptive services coupled with financial incentives to attend follow-up visits to assess contraceptive satisfaction was a significantly more effective and cost-beneficial intervention than without incentives or with usual care, according to a prospective randomized clinical trial in JAMA Psychiatry.
Read More
Oral contraceptives and risk of cardiac events in women with congenital long-QT syndrome
August 18th 2021Women with congenital long-QT syndrome (LQTS) have an increased risk of cardiac events, including sudden cardiac death, after the onset of adolescence, perhaps due to the effects of estrogen and progesterone on cardiac potassium channels.
Read More